World Tobacco Conference
Accused of Prostitution
Boston University School of Public Health professor Michael Siegel today accused the 14th World Conference on Tobacco or Health of selling the scientific integrity of the global tobacco control movement to pharmaceutical influence. The conference is scheduled for Mumbai, India in March 2009. Its website indicates that Pfizer and GlaxoSmithKline, makers of a growing array of quit smoking "medicines" will serve as conference sponsors.
"How can you objectively discuss the population impact of NRT (nicotine replacement therapy) use at a conference sponsored by two of the leading nicotine replacement therapy drug companies," asks Dr. Michael Siegel, a preventive medicine physician who has been active in tobacco control for 20 years?
"How can you objectively discuss effective national strategies for smoking cessation," or "all aspects of individual and population-based approaches to helping people quit smoking at a conference sponsored by two of the leading nicotine replacement therapy drug companies." "You can't," he asserts.
There is growing awareness that while pharmaceutical quitting products consistently produce victories over placebo users in clinical trials, that those trials were not blind as claimed. Every cessation pharmacology product to date has fallen flat on its face in real-world use, and new evidence suggests that Champix and Chantix (varenicline) may be joining them.
"The drugs are approved because they've shown in FDA studies that they're better than placebo," says Dr. Edward Levin, a psychopharmacological researcher at Duke University Medical Center in Raleigh, N.C., as quoted yesterday in a CNN Money Chantix article. "But being better than placebo doesn't take a whole lot."
As early as 1984 the U.S. FDA was aware that the scientific foundation of clinical trials, placebo group comparisons, was shaky and in trouble. It was then that researchers resorted to the extreme of using small amounts of nicotine in placebo gum as a masking agent, a practice that continued in nicotine patch studies.
Could it be that drug addiction is the only pharmacology research area where comparisons with placebo control groups is actually a license to steal? Is it possible to hide from the average quitter the fact that placebo group assignment has thrown them into full-blown nicotine withdrawal, or hide active group assignment when chemically elevated dopamine output is providing a noticeable reduction in withdrawal intensity from prior quitting attempts?
While promising to double cessation rates, in October 2006 the CDC was forced to report that decline in the U.S. smoking rate had ground to a halt. Is cessation pharmacology actually undercutting worldwide cessation? Is toying with lengthy replacement nicotine weaning schemes actually costing smokers their lives?
Is it realistic to think that such concerns can be openly discussed and debated at a conference where those sponsoring the conference could potentially lose billions in profits if blinding concerns and real-world use findings were granted full and fair hearings?
Whether looking at National Cancer Institute survey data or data following smoking patients of Australian family practice physicians, real-world quitting method studies continue to find that those quitting "on their own" have higher long-term success rates than those using replacement nicotine or bupropion (Zyban).
Since September 11, 2002, industry consultants have countered with a wide range of theories and excuses that all miss one central point, that the continuing blanket marketing representation that these products will increase a smoker's chances of quitting is false.
"The preoccupation with nicotine replacement therapy, spurred on by the infusion of pharmaceutical dollars into the tobacco control field, is causing us to lose sight of the actual root of the problem: the addictive state itself," writes Dr. Siegel. "And that is a shame, because it may be severely hampering our efforts to help smokers quit."
A 2004 study by GlaxoSmithKline consultants found that, then, 37% of nicotine gum users were hooked on the cure. U.S. Presidential candidate Senator Barak Obama admits having been on nicotine gum for more than a year. During varenicline (Chantix/Champix) clinical trials the FDA permitted those who started using replacement nicotine after ending 12 weeks of varenicline use to be counted as successful varenicline quitters at long-term follow-up.
While replacement nicotine clearly poses far less health risk than smoking, it is just as obvious that those dependent upon it have not arrested their chemical dependency, and remain extremely vulnerable to returning to smoking.
Has the pharmaceutical industry invented a new definition of quitting, one that only refers to quitting one form of nicotine delivery, smoke? Why in nearly all clinical trials did it fail to examine nicotine levels in blood, urine or saliva of those declared to have successfully quit? Is the industry's lack of regard for whether a smoker arrests their chemical dependency closer to public health interests or those of the tobacco industry?
But concerns about taking our eye off the ball may be too late. At this moment the FDA is being petitioned to allow pharmaceutical nicotine to invade neighborhood convenience stores, to do open battle against tobacco, by being sold in daily-dose packs beside cigarettes.
While cleaner delivery and harm reduction make sense, intensifying an already ragging battle at the neighborhood candy, chip and soda store does not. Until now, youth were taught that NRT was for quitting. What consequences will flow when an ocean of NRT signs start screaming messages about fast, clean, safe, pleasure, flavor and taste? Should the initial experiment be upon an entire nation?
Are pharmaceutical industry chemical enslavement objectives really any different from the tobacco industry's? Is the 14th World Conference on Tobacco or Health being played like a fiddle?
A once secret 1972 R.J. Reynolds document states, "In a sense, the tobacco industry may be thought of as being a specialized, highly ritualized and stylized segment of the pharmaceutical industry. Tobacco products, uniquely, contain and deliver nicotine, a potent drug with a variety of physiological effects." "If nicotine is the sine qua non of tobacco products and tobacco products are recognized as being attractive dosage forms of nicotine, then it is logical to design our products -- and where possible, our advertising -- around nicotine delivery rather than "tar" delivery or flavor." "Hopefully, with time we will be able to develop sophisticated and improved minimum dosage forms for nicotine which will be more satisfying to the user and free of alleged health hazards."
"To prostitute oneself is defined as 'selling one's abilities, talent, or name for an unworthy purpose,'" writes Dr. Siegel. "By accepting Big Pharma money in order to fund its symposium, the World Conference on Tobacco OR Health, in my opinion, is selling its name for what I consider to be an unworthy purpose. The Conference is allowing itself to be used as a pharmaceutical marketing agent, simply to make money, when the over-reliance on pharmaceutical agents is in my opinion one of the main reasons why smoking cessation efforts and policies have been so ineffective."
- Cold turkey clobbers e-cigs, NRT and Chantix, John R. Polito, 07/18/18
- JNCI study finds pharmaceutical stop smoking aids ineffective, John R. Polito, 12/22/17
- Nicotine cessation: lost in the deserts of Abu Dhabi, John R. Polito, 03/16/15
- 10 studies screaming "leave replacement nicotine alone!" John R. Polito, 01/01/15
- The Surgeon General's Reports: 50 years of cessation ignorance, John R. Polito, 01/20/14
- Australia's half-baked quit smoking campaign, John R. Polito, 11/3013
- The Great American quit smoking sham, John R. Polito, 11/18/13
- BMJ's non-publication policy should extend to pharma's nicotine, John R. Polito, 10/19/13
- Gallup Poll: cold turkey 48 times smarter than Nicorette, John R. Polito, 08/26/13
- Cold turkey quitting still king, John R. Polito, 07/15/13
- Pharma bias destroys ITC quit smoking medication study, John R. Polito, 08/20/12
- Potent warnings, horrible quitting advice: what's the CDC smoking? John R. Polito, 03/17/12
- Replacement Nicotine's Killing Fields, John R. Polito, 02/11/12
- Chantix study joins negative findings omissions club, John R. Polito, 12/22/11
- Dying truths about quitting smoking methods, John R. Polito, 11/14/11
- Bias against cold turkey quitting apparent in literature, Dr. Michael Siegel, 11/03/11
- Suicidal behavior and depression in smoking cessation treatments, Moore TJ et al, 11/03/11
- Study finds cold turkey quitting more effective but concludes opposite, Dr. Michael Siegel, 11/01/11
- Tar wars over smoking cessation, BMJ Link, Professor Simon Chapman, 08/08/11
- Is a 14% Chantix success rate worth risking death?, John R. Polito, 06/14/11
- Chantix fails to defeat nicotine patch, John R. Polito, 03/30/11
- Chantix serious injuries exceed 8,500, John R. Polito, 01/28/11
- Champix - Chantix worth questioned - John R. Polito, 01/06/11
- GlaxoSmithKline Continues Defrauding Smokers - John R. Polito, 11/02/10
- Little communication in failed war against smoking - John R. Polito, 08/08/10
- Smokefree.gov really Buymeds.now - John R. Polito, 03/24/10
- Five facts Chantix ads keep hidden - John R. Polito, 12/29/09
- Pfizer's Chantix Continues Killing Quitters - John R. Polito, 10/22/08
- Chantix and Champix mental health safety assurances contrary to evidence - John R. Polito, 06/12/08
- Chantix blamed for 3,063 serious injuries and 78 deaths - John R. Polito, 05/13/08
- Strong Safety Signal Seen for New Varenicline Risks - ISMP, 05/21/08
- U.S. quit smoking policy integrity drowns in pharmaceutical influence - John R. Polito, 05/13/08
- Does updated tobacco treatment "Guideline" reflect sham science? - John R. Polito, 05/05/08
- FDA pulls video clip admitting Chantix suicide link - John R. Polito, 04/03/08
- New FDA Chantix suicide risk video clip raises concerns - John R. Polito, 04/02/08
- FDA Chantix Handling Betrayed Public Health - John R. Polito, 02/08
- Windows media clip of WhyQuit's candid views on Chantix & Champix: 18mb video for dial-up users | high res 53mb format | and 7mb audio only format, length 48 minutes, recorded 10/19/07 by Joel Spitzer
- Can Chantix Cause Depression? - The People's Pharmacy, 09/19/07
- Flawed research equates placebo to cold turkey - John R. Polito, 03/07
- Nicotine Fix - Behind Antismoking Policy, Influence of Drug Industry - Kevin Helliker, 02/07
- WSJ Highlights Financial Conflicts of Chair of Federal Guidelines Panel - Michael Siegel, MD 02/07
- Nixing the Patch: Smokers quit cold turkey - Ken Millstone, 02/07
- New Study Challenges Thinking on Use of NRT During Pregnancy - Michael Siegel, MD, 02/07
- Nicotine for the Fetus, the Infant and Adolescent - H.K. Ginzel, MD, 02/07
- The secret to quitting smoking - John R. Polito, 01/07
- Financial Ties Between Guideline Panels and Big Pharma Run Deep - Michael Siegel, MD, 01/07
- Chantix - an 8 in 10 failure rate or worse? - John R. Polito, 12/06
- Do physician's have a legal duty to ignore Guideline Recommendation 7? - John R. Polito, 12/06
- Is the U.S. government's quitting policy killing smokers? - John R. Polito, 10/06
- Will Chantix really help me quit smoking? - John R. Polito, 08/06
- Conference Sponsorship by Pharma Precludes Objective Symposium - Michael Siegel, MD 07/06
- 13th World Conference on Tobacco or Health Drenched in Nicotine - John R. Polito, 07/06
- Cold Turkey Twice as Effective as NRT or Zyban - John R. Polito, 05/06
- Nicotine Not Medicine, Its Use Not Therapy - John R. Polito, 04/06
- GlaxoSmithKline Attacks Cold Turkey Quitting - John R. Polito, 12/05
- UK Guidance for NRT use in pregnancy and by children - ASH London, 12/05
- June 2000 Guideline Chairman Michael Fiore's Testimony - see PDF pages 14 & 15, 05/05
- The Nicotine Patch, Gum and Lozenge - Mounting Evidence of a Sham - John R. Polito, 04/05
- 40 Years of Progress? - Joel Spitzer, 10/04
- Widespread Blinding Failures Put NRT Studies in Serious Question - John R. Polito, 06/04
- Nicotine Gum Maker's Concern Raises Concerns - John R. Polito, 05/04
- A Quitter's Dilemma: Hooked on the Cure - New York Times, 05/04
- Quebec CT Quitters Disprove "Double Your Chances" NRT Assertion - John R. Polito, 04/04
- Are nicotine weaning products a bad joke? - John R. Polito, 10/03
- Is CT Quitting More Productive & Effective than NRT? - John R. Polito, 07/03
- Are Teens Getting Hooked on NRT? - John R. Polito, 06/03
- March 2003 OTC NRT Meta-Analysis Finds 93% Midyear Relapse Rate - John R. Polito, 03/03
- Quitting Methods - Who to Believe? - Joel Spitzer, 2003
- JAMA Study Concludes NRT is Ineffective - John R. Polito, 09/02
- Real-World Nicotine Patch and Gum Rates - John R. Polito, 06/02
- Does the OTC Nicotine Patch Really Double Your Chances of Quitting? - John R. Polito, 04/02
- Is Nicotine Replacement Therapy The Smoker's Last Best Hope? - John R. Polito, 11/00
- Financial Disclosures for June 2000 Guideline Panel - U.S. Public Health Service, 06/00
- June 2000 Guideline Recommendation 7 - pharmacotherapy use by all quitters - 06/00
How to Quit Smoking
Our Free E-books
Read both & destroy fear driven anxieties!
Discover Smart Turkey Quitting
- WhyQuit.com - WhyQuit is the Internet's oldest forum devoted to the art, science and psychology of cold turkey quitting, the stop smoking method used by the vast majority of all successful long-term ex-smokers.
- Nicotine Addiction 101 - WhyQuit's basic guide to understanding nicotine dependency.
- Nicotine Cessation Topic Index - An alphabetical subject matter index to more than a thousand nicotine cessation articles, videos and support group discussions.
- Joel's Library - Joel Spitzer began presenting stop smoking clinics and seminars in 1976. WhyQuit's education director since 2000, Joel's Library is home to his life's work. It includes Joel's "Daily Quitting Lesson Guide," more than 100 original stop smoking articles, his free ebook "Never Take Another Puff," and to his ever growing collection of more than 400 stop smoking videos.
- "Freedom from Nicotine - The Journey Home" - Written by John R. Polito, a former 30-year heavy smoker and WhyQuit's 1999 founder, Freedom from Nicotine shares the science underlying nicotine dependency and successful abrupt nicotine cessation.
- Turkeyville - Imagine surrounding yourself with more than 10,000 cold turkey quitters. Turkeyville is a Facebook support group exclusively for cold turkey quitters.
- Freedom - Freedom was WhyQuit's original 1999 stop smoking support group. No longer accepting members, its 453,000 archived posts continue to share recovery insights.